ECEverton Cazzo

Everton Cazzo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Everton Cazzo has a total of 341 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Long-Term Pancreatic Function, Reconstruction Durability, and Disease Control After Pancreas-Preserving Total Duodenectomy: Systematic Review and Single-Arm Meta-Analysis

    by Philipe Franco Do Amaral Tafner, Giulia Trucolo de Brito, Morgana Danúbia Gomes de Souza Bonfitto, Helena Paes de Almeida de Saito, Martinho Antonio Gestic, Murillo Pimentel Utrini, Francisco Callejas Neto, Everton Cazzo

  • Open Access

    Erector Spinae Block in Bariatric Surgery: a Systematic Review and Meta-Analysis of Randomized Controlled Trials

    by Giovanna Macanhã Scremin, Pedro Bicudo Bregion, Victor Kenzo Ivano, Gabriel José Souto Maior de França, Julia Bueno de Oliveira Alves, Luísa Zanelatto de Araujo, Pandora Eloa Oliveira Fonseca, Leonardo Halamy Pereira, João Gabriel Romero Braga, Everton Cazzo

    Introduction: Obesity is a growing global health issue, and bariatric surgery offers effective weight loss outcomes. Postoperative pain management remains a challenge, with multimodal analgesia and regional blocks like the erector spinae plane (ESPB) showing promise. This review aims to evaluate the efficacy of the Erector Spinae Plane Block (ESPB) on key postoperative outcomes in bariatric surgery, specifically its impact on opioid consumption, pain management, and complication rates. Methods: We conducted a systematic review and meta-analysis following PRISMA guidelines. In January 2025, we conducted a comprehensive search across PubMed, Embase, and Cochrane databases for studies comparing erector spinae block in bariatric surgery. Data extraction was standardized, focusing on postoperative analgesic consumption, pain control, intraoperative opioid consumption, respiratory complications and PONV. Statistical analysis was performed using RevMan 9.0.0, with random-effects models. Heterogeneity was assessed using Cochran’s Q test and I² statistic. Results: The analysis included 9 randomized controlled trials (RCTs) with a total of 553 patients. ESP block significantly reduced total opioid consumption (MD -9.53, 95% CI -15.10 to -3.96, p = 0.0008), pain scores like NRS (MD -1.15, 95% CI -1.76 to -0.55, p = 0.0002). Despite heterogeneity across studies, ESPB was associated with reduced opioid use and better pain control. ESP block was associated with a significant reduction in VAS pain scores during the first 12 h after surgery, although substantial heterogeneity was observed across studies. Using the ESP block significantly reduced the incidence of postoperative nausea and vomiting, with consistent results across studies (I² = 0%). There was no significant difference in the incidence of respiratory complications between the study groups. Conclusion: ESPB is associated with significant reductions in postoperative pain scores and total opioid consumption, while no significant difference in respiratory complications was observed between the groups.

  • Open Access

    Late Hiatal Hernia after Roux-en-Y Gastric Bypass: A Systematic Review

    by Pedro Bicudo Bregion, Josélio Rodrigues de Oliveira-Filho, João Gabriel Romero Braga, Everton Cazzo, Victor Kenzo Ivano

  • Open Access

    Hormone PYY does not Explain the Variability in Weight Loss After Roux-en-Y Gastric Bypass: Evidence From a Meta-Analysis.

    by Giovanna Macanhã Scremin, Pedro Bicudo Bregion, Ana Cláudia Portes Nascimento, Júlia Marchiori Fein, Leonardo Halamy Pereira, Victor Kenzo Ivano, Everton Cazzo

    Background: Peptide YY (PYY) plays a key role in postprandial satiety and is markedly increased after Roux-en-Y gastric bypass (RYGB). While GLP-1 has been widely studied, the role of PYY as a predictor of weight loss success remains unclear. Some patients are considered non-responders, achieving < 50% excess BMI loss (EBMIL) or experiencing significant weight regain. This systematic review and meta-analysis aimed to compare fasting PYY levels and postprandial area under the curve (AUC) between RYGB responders and non-responders. Methods: Following PRISMA guidelines, PubMed, Embase, and Cochrane databases were searched for observational or interventional studies assessing PYY in adult RYGB patients stratified by weight loss response. Primary outcomes were fasting PYY levels and PYY AUC after standardized meals. Random-effects meta-analysis was conducted using Review Manager 5.4. Mean differences (MD) with 95% confidence intervals (CI) were calculated. Heterogeneity was assessed via Cochran’s Q and I². Results: Five studies were included in the systematic review (92 non-responders and 89 responders), contributing to the fasting PYY meta-analysis, which showed no significant difference between groups (MD 1.71 pg/mL; 95% CI − 5.22 to 8.63; I² = 0%). Four studies reported AUC, also showing no difference (MD 53.16 pg·min/mL; 95% CI − 1726.29 to 1832.61; I² = 0%). Several studies observed lower satiety scores and attenuated appetite suppression in non-responders despite similar PYY profiles. No significant genetic variants in PYY or its receptor were associated with weight loss outcomes. Conclusion: RYGB responders and non-responders have comparable fasting and postprandial PYY concentrations. These findings suggest that differential weight loss after RYGB is likely mediated by factors beyond PYY secretion, including neural, behavioral, or other hormonal mechanisms.

  • Open Access

    Patients with Obesity Undergoing Roux-En-Y Gastric Bypass Versus Fundoplication for Refractory GERD: A Systematic Review and Meta-Analysis

    by Giovanna Macanhã Scremin, Pedro Bicudo Bregion, Victor Kenzo Ivano, Pandora Eloá Oliveira Fonseca, Everton Cazzo

    Background: Gastroesophageal reflux disease (GERD) significantly impairs quality of life and is associated with complications such as Barrett’s esophagus and esophageal adenocarcinoma. Obesity exacerbates GERD pathophysiology by elevating intra-abdominal pressure, making treatment more difficult. Current evidence suggests that Roux-en-Y gastric bypass (RYGB) offers superior outcomes compared to fundoplication in patients with severe obesity (BMI ≥ 40 kg/m²). This review aims to critically evaluate fundoplication versus RYGB in the population with obesity and GERD. Methods: We conducted a systematic review and meta-analysis in accordance with PRISMA guidelines. We performed a comprehensive search across PubMed, Embase, and Cochrane databases for studies comparing fundoplication versus RYGB in patients with obesity and GERD. Data extraction was standardized, focusing on intraoperative complications, operative time, length of hospital stay, reoperation, postoperative complications, postoperative dysphagia, and DeMeester score. Statistical analysis was performed using Cochrane RevMan (Review Manager 9.7.1), employing random-effects models. Heterogeneity was assessed using Cochran’s Q test and I² statistic. Results: The analysis included 7 observational studies. We found no differences in complication rates after sensitivity analysis. There were no differences in dysphagia, reoperation rate, operative time and length of stay. At a weighted mean follow-up of 42.3 months (range: 19.6 to 52.0) for fundoplication and 35.2 months (range: 14.6 to 49.0) for RYGB, GERD resolution, measured by the DeMeester score, slightly favored fundoplication, although the absolute difference was not clinically relevant. Regarding weight outcomes, RYGB demonstrated significantly higher total weight loss (TWL) at the 12-month follow-up. Conclusion: Fundoplication appears statistically superior for GERD resolution postoperatively, but the difference is not clinically relevant. RYGB has a higher TWL. Both procedures are safe for GERD control in patients with obesity. The choice between procedures should weigh reflux severity, complication risks, and metabolic diseases associated with obesity. Larger studies are needed to clarify the impact of surgical timing and patient-specific factors.


  • Open Access

    Effectiveness of Prophylactic Doses of Tranexamic Acid in Reducing Hemorrhagic Events in Bariatric Surgery: A Systematic Review and Meta-Analysis

    by Pedro Bicudo Bregion, Josélio Rodrigues de Oliveira-Filho, Victor Kenzo Ivano, Everton Cazzo

    Postoperative bleeding is a major complication in bariatric surgery, contributing to increased morbidity, longer hospital stays, and healthcare costs. Tranexamic acid (TXA), an antifibrinolytic agent, has shown promise in reducing surgical blood loss in various specialties. However, there is still no consensus regarding its effectiveness and safety in bariatric surgery. We performed a systematic review and meta-analysis to evaluate the impact of prophylactic TXA on hemoglobin levels, procedural duration, and hospital length of stay in bariatric surgery patients. PubMed, Embase, and Cochrane Central were searched for randomized controlled trials (RCTs) and observational studies comparing TXA and non-TXA groups in bariatric surgery up to November 2024. Data were independently extracted by two reviewers, and risk of bias was assessed using ROBINS-I and RoB-2. Outcomes were assessed using random-effects models, with heterogeneity evaluated by I2 statistics. Sensitivity analyses and publication bias assessments were also performed. Nine studies (2 RCTs and 7 observational studies) involving 1,956 patients were included. TXA significantly improved hemoglobin levels (MD 0.46 g/dL; 95% CI 0.08–0.84; P = 0.02), reduced procedure duration (MD -9.70 min; 95% CI -14.79 to -4.61; P < 0.01), and shortened hospital length of stay (MD -0.19 days; 95% CI -0.31 to -0.07; P < 0.01). No significant increase in thrombotic events was observed. Sensitivity analyses confirmed the robustness of these findings despite high heterogeneity. Prophylactic TXA may significantly reduce perioperative bleeding (smaller hemoglobin decline), operative time, and length of hospital stay in bariatric surgery, without a signal of increasing thrombotic risks, but this should be interpreted with caution given small sample sizes and low event rates. These results support the integration of TXA into perioperative care protocols for bariatric surgery, offering potential benefits in patient outcomes and surgical efficiency.


  • Outcomes of Bariatric Surgery for Idiopathic Intracranial Hypertension: A Systematic Review and a Single-Arm Meta-analysis

    by Julia Bueno de Oliveira Alves, Pedro Bicudo Bregion, Gabriel José Souto Maior de França, Luísa Zanelatto de Araújo, Giovanna Macanhã Scremin, Pandora Eloa Oliveira Fonseca, Leonardo Halamy Pereira, João Gabriel Romero Braga, Victor Kenzo Ivano, Everton Cazzo

    Background and Aims Idiopathic intracranial hypertension (IIH) is characterized by elevated intracranial pressure (ICP) in the absence of structural pathology and is strongly linked to obesity. Weight reduction remains the only disease-modifying therapy, and bariatric surgery (BS) may offer durable ICP control and symptom improvement. This study evaluated postoperative clinical, visual, and physiological outcomes in patients with IIH undergoing BS. Methods A systematic review and single-arm meta-analysis were conducted in accordance with PRISMA and Cochrane guidelines. PubMed, Embase, and CENTRAL were searched through April 2025. Eligible studies included obese patients with IIH who underwent any bariatric procedure. Primary outcomes were remission of headache, papilledema, pulsatile tinnitus, and cessation of IIH-related medications. Secondary outcomes included changes in visual parameters, weight loss, BMI reduction, and CSF opening pressure. Risk of bias was assessed with ROBINS-I for observational studies and RoB-2 for randomized trials. Heterogeneity was explored through leave-one-out analyses, Baujat influence plots, and meta-regression. Results Nine studies (eight observational, one randomized clinical trial) comprising 229 patients were included. Patients were predominantly women with severe obesity (BMI 40.4–49.0 kg/m²) and markedly elevated baseline CSF pressures (32–45 cmH₂O). Pooled estimates demonstrated high rates of improvement across outcomes, including headache (84.6%), visual field deficits (83.3%), pulsatile tinnitus (88.7%), and visual symptoms (98.1%). Papilledema resolution approached 98% but showed wide prediction intervals due to small samples and complete-event studies. Medication cessation occurred in 63.3% of patients. CSF pressure decreased significantly (mean − 13.24 cmH₂O), and total weight loss averaged 28.5%, with excess weight loss of 65.7%. Meta-regression indicated that higher baseline CSF pressure and higher proportions of RYGB predicted greater CSF reduction, while preoperative BMI and the proportion of SG significantly moderated postoperative weight loss. Influence diagnostics identified Wills et al. and Lainas et al. as key contributors to heterogeneity in symptom and medication outcomes, and Mollan et al. as the principal driver of variability in weight-loss estimates. Reported complications were infrequent and predominantly mild, and no deaths were noted, although follow-up completeness varied. Risk of bias was low in the randomized trial but moderate to serious in the observational cohorts. Conclusion Bariatric surgery in patients with IIH is associated with favorable postoperative outcomes, including high rates of symptom improvement and reduced medication use. While these findings support the potential disease-modifying role of surgical weight loss, they should be interpreted with caution given the single-arm nature of the available evidence and the predominance of observational studies.


  • Open Access

    RELATIONSHIP BETWEEN TIMING OF SURGERY AFTER PREOPERATIVE BILIARY DRAINAGE AND OUTCOMES FOLLOWING PANCREATODUODENECTOMY

    by Philipe Franco Do Amaral Tafner, Bruna Mattos Vanetti de Albuquerque, Fernando Girardi da Silva, Martinho Antonio Gestic, Murillo Pimentel Utrini, Francisco Callejas-Neto, Everton Cazzo

    Background: The role and optimal timing of surgery following preoperative biliary drainage (PBD) in patients undergoing pancreatoduodenectomy remain controversial. Early surgery may be influenced by procedure-related inflammation, whereas delayed intervention may increase infectious complications due to biliary colonization. Objective: To evaluate the impact of the interval between biliary drainage and pancreatoduodenectomy on postoperative outcomes and its association with biliary contamination. Methods: This retrospective cohort study included 239 patients undergoing pancreatoduodenectomy between 2013 and 2025. Of these, 174 (73%) underwent PBD via endoscopic retrograde cholangiopancreatography. Patients were stratified by interval between drainage and surgery: ≤2 weeks, 3-6 weeks, and >6 weeks. The primary outcome was 90-day mortality; secondary outcomes included major complications (Clavien-Dindo ≥III). Multivariable logistic regression adjusted for confounders. Results: Surgery at 3-6 weeks was associated with the lowest rates of major complications (31.7%) and 90-day mortality (9.7%), compared with ≤2 weeks (57.1%; 28.6%) and >6 weeks (40.6%; 23.2%). Surgery outside this interval increased 90-day mortality risk (OR 2.9, 95%CI 1.07-7.83). Biliary colonization rose with longer intervals, exceeding 90% after three weeks. Conclusion: A 3-6 week interval between biliary drainage and pancreatoduodenectomy is associated with improved outcomes, suggesting an optimal window balancing inflammation and bacterial colonization.

  • Open Access

    PANCREATIC NEUROENDOCRINE TUMORS: CLINICOPATHOLOGICAL ANALYSIS AND POSTOPERATIVE SURVIVAL FOLLOWING SURGICAL RESECTION-A DECADE OF EXPERIENCE AT A TERTIARY UNIVERSITY HOSPITAL

    by Mariana Martins Sanches Ferreira, Philipe Franco Do Amaral Tafner, Martinho Antonio Gestic, Murillo Pimentel Utrini, Francisco Callejas-Neto, Everton Cazzo

    Background: Pancreatic neuroendocrine tumors (PNETs) are rare neoplasms of the digestive system, with variable prognoses and biological behaviors. Surgical resection remains the mainstay of treatment. Objective: To evaluate the clinicopathological characteristics and surgical outcomes of patients with PNETs who underwent resection at the Hospital de Clínicas, UNICAMP. Methods: This is a retrospective cohort study including 24 patients who underwent surgical resection between 2013 and 2023. Clinical, demographic, histopathological, and survival data were analyzed. The primary outcome was overall survival. Results: The mean age was 53.9 ± 14.4 years, with a predominance of female patients (66.7%). Most tumors were nonfunctioning (79.1%), with abdominal pain (79.2%) and weight loss (50%) being the most common symptoms. The surgical procedures performed were distal pancreatectomy (54.2%), pancreaticoduodenectomy (41.6%), and enucleation (4.2%). Histological classification revealed 62.5% grade 2 tumors, 33.3% grade 1, and 4.2% MiNEN. Mean overall survival was 70.4 ± 58 months. There was a trend toward longer survival in grade 1 tumors (98 ± 68.1 months) compared to grade 2 (59.1 ± 49.5 months; P=0.06). Postoperative mortality was 8.3%, associated with pancreaticoduodenectomy. Conclusion: Histological grading remains a key prognostic factor in PNETs. Surgical resection remains the cornerstone of treatment. Multicenter studies are necessary to validate these findings on a larger scale.

  • Open Access

    Polymicrobial Bacteriobilia Is Associated with 90-Day Mortality After Pancreaticoduodenectomy

    by Philipe Franco Do Amaral Tafner, Fernando Girardi da Silva, Alice Lily Carranza Cunha, Isabella Ferreira de Oliveira dos Santos, Martinho Antonio Gestic, Murillo Pimentel Utrini, Francisco Callejas-Neto, Everton Cazzo

    Introduction: Bacteriobilia is common in patients undergoing pancreaticoduodenectomy (PD), particularly after preoperative biliary drainage. Its impact on perioperative outcomes and extended early mortality remains controversial. This study evaluated the association between intraoperative bile cultures and early postoperative outcomes following PD for periampullary tumors. Methods: This retrospective cohort study included 176 patients who underwent PD with intraoperative bile culture between 2013 and 2024 at a tertiary center. Patients were stratified according to bacteriobilia status. Perioperative variables, postoperative complications (Clavien-Dindo classification), and mortality at 30, 60, and 90 days were analyzed. Multivariable logistic regression identified independent predictors of bacteriobilia and early mortality. Results: Bacteriobilia was detected in 146 patients (83%), with 70% presenting polymicrobial cultures. Preoperative ERCP (OR 23.48; 95% CI 6.47-85.22; p<0.001) and biliary stent placement (OR 8.78; 95% CI 1.98-38.86; p=0.004) independently predicted bacteriobilia. Overall mortality was 12.5% at 30 days, 16.0% at 60 days, and 16.5% at 90 days. Bacteriobilia per se was not associated with increased major morbidity or mortality. However, polymicrobial bile cultures were independently associated with higher mortality at 60 (OR 2.32; 95% CI 1.35-3.88; p=0.004) and 90 days (OR 20.07; 95% CI 1.32-304.81; p=0.031), after adjustment for vascular resection, bleeding, transfusion, and severe complications. Conclusions: Although bacteriobilia is highly prevalent after preoperative biliary drainage, it does not independently worsen perioperative outcomes. Polymicrobial bile cultures were associated with increased 60- and 90-day mortality and may identify a subgroup of patients with greater biological and perioperative complexity, highlighting the importance of microbiological stratification and extended mortality assessment after PD.